Page History

...

• Age ranges (e.g., adult, pediatric, infant, junior, adolescent)
  • Exception: Vaccine products MP-only concepts maybe modeled with Has target population (attribute) that specifies a target population.
• Adjuvants
• Allergy immunotherapy products
  • Should be represented in a national extension because of the manufacturer-specific variability regarding standardization and expression of strength.
• Ayurvedic medicine
• Brand names
• Color (e.g., color of tablet, capsule, or solution)
• Composite products
• Excipients
• Flavors
• Investigational products/Products under development but not marketed in any member country
  • Exceptions may be made on a case-by-case basis (e.g., adding investigational products that are being widely used in pandemic).
• Medicinal product (MP) and Medicinal product form (MPF) concepts without Clinical drug (CD) descendants
  • There are historical concepts that do not have descendant CDs; this is not a pattern that will continue moving forward (e.g., MPs and MPFs are not created unless needed to support classification of a CD).
• Packs
• Products intended only for non-human use
• Products no longer marketed or available for sale
  • Existing concepts representing products that are no longer marketed or available for sale will be retained as active concepts in the International Release.  Requests for new content will be considered for inclusion on a case-by-case basis.
• Relevant omissions (e.g., sugar-free, preservative-free)
• Routes of administration not explicitly represented
• Sterility
• Tall man lettering
  • Descriptions that include tall man lettering [partial capitalization of drug names to distinguish from similar sounding drugs] should be authored in a national or local extension.
• Traditional medicine products

Table of Contents

...

International Unit in Clinical Drugs Descriptions

International Unit as a description is arbitrary, and to be understood, each product requires reference to a particular bioefficacy specification for that entity.  Therefore, international is neither a meaningful nor comparable description at Clinical Drug level.  International unit will be represented as unit in Clinical Drug descriptions.  Abbreviations will not be used.

For example,

• • 1237145006 |Product containing precisely octocog alfa 1000 unit/1 vial powder for conventional release solution for injection (clinical drug)|